Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 25,084 | 22,191 | 28,168 | 29,003 | 30,722 |
| Cost of Goods | 11,238 | 10,299 | 12,487 | 11,985 | 12,589 |
| Gross Profit | 13,846 | 11,892 | 15,681 | 17,018 | 18,133 |
| Operating Expenses | 31,780 | 30,674 | 34,310 | 36,872 | 32,414 |
| Operating Income | -17,696 | -18,483 | -18,142 | -18,869 | -13,692 |
| Interest Expense | 1,460 | 1,454 | 1,453 | 1,453 | 1,453 |
| Other Income | -638 | -161 | -44 | -324 | 2,062 |
| Pre-tax Income | -19,794 | -20,098 | -19,639 | -20,646 | -13,083 |
| Income Tax | -2,099 | -309 | -1,022 | -762 | -204 |
| Net Income Continuous | -17,695 | -19,789 | -18,617 | -19,884 | -12,879 |
| Net Income | $-17,695 | $-19,789 | $-18,617 | $-19,884 | $-12,879 |
| EPS Basic Total Ops | -0.61 | -0.68 | -0.64 | -0.69 | -0.45 |
| EPS Basic Continuous Ops | -0.61 | -0.68 | -0.64 | -0.69 | -0.45 |
| EPS Diluted Total Ops | -0.61 | -0.68 | -0.64 | -0.69 | -0.45 |
| EPS Diluted Continuous Ops | -0.61 | -0.68 | -0.64 | -0.69 | -0.45 |
| EBITDA(a) | $-12,852 | $-13,956 | $-13,662 | $-14,504 | $-10,007 |